WO2002004004A1 - Procedes a haute pression/cisaillement eleve de preparation de dispersions contenant des cires et autres semi-solides et huiles - Google Patents

Procedes a haute pression/cisaillement eleve de preparation de dispersions contenant des cires et autres semi-solides et huiles Download PDF

Info

Publication number
WO2002004004A1
WO2002004004A1 PCT/US2001/021746 US0121746W WO0204004A1 WO 2002004004 A1 WO2002004004 A1 WO 2002004004A1 US 0121746 W US0121746 W US 0121746W WO 0204004 A1 WO0204004 A1 WO 0204004A1
Authority
WO
WIPO (PCT)
Prior art keywords
wax
dispersion
oil
solvent
agents
Prior art date
Application number
PCT/US2001/021746
Other languages
English (en)
Inventor
Joseph D. Ceccoli
Michael Ross
James M. Wilmott
Todd Coleman
Timothy K. Crawford
Original Assignee
Collaborative Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collaborative Technologies, Inc. filed Critical Collaborative Technologies, Inc.
Priority to US10/332,395 priority Critical patent/US20040018250A1/en
Priority to AU2001275888A priority patent/AU2001275888A1/en
Publication of WO2002004004A1 publication Critical patent/WO2002004004A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/893—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/33—Free of surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Definitions

  • the present invention relates to an oil-in-water dispersion composed of one or more waxes or hydrophobic semi-solids, a dispersion initiator, optionally one or more plasticizing agents or solvents and/or co-solvents, and water.
  • the invention also describes a method for preparing these oil-in-water dispersions and their use in topical, oral, anal, ophthalmic, vaginal, otic and nasal formulations.
  • Waxes are commonly used in formulations for topically applied pharmaceutical or cosmetic products for their relatively high water resistance, their ability to modify the textural, rheological and tactile properties of products. Waxes provide a richer feel to products during the application process and provide afterfeel properties ranging from smooth and soft to a heavy coated feel.
  • waxes are typically either solubilized in a suitable hydrophobic fluid, and/or are incorporated into water-in-oil (W/O) or oil-in- water (O/W) emulsions.
  • W/O water-in-oil
  • O/W oil-in- water
  • Emulsions are prepared by adding emulsifiers or surfactants to the hydrophobic and hydrophilic phases of a composition to reduce the surface tension of water and the interfacial tension between the hydrophobic and hydrophilic phases.
  • the hydrophilic phase containing water and water compatible emulsifiers and components, is prepared and heated with mixing to a temperature in excess of 70° C.
  • a hydrophobic phase containing the waxes and other non-polar ingredients such as oils, and oil compatible emulsifiers and components, is heated to temperatures sufficient to melt the wax and mixed until a homogeneous preparation results.
  • the hydrophobic phase is added to the hydrophilic phase and mixed with suitable agitation to intimately intermingle the phases.
  • the total composition is then cooled to remove the excess heat until the composition reaches ambient temperature.
  • Standard emulsion preparations are costly to manufacture due to a variety of factors including the high amount of energy required to heat the preparation, the specialized equipment required to process the emulsion such as specialized pumps and cooling/heating equipment and longer processing times.
  • Emulsifiers or surfactants also unfortunately reduce the water resistivity of the formulations because surfactants (and other emulsifiers) facilitate the removal of the formulations from the surface of the skin when exposed to water.
  • Surfactants also strip protective layers from the lipid barrier of the skin or the lipid bilayer of epithelial cell membranes leaving the skin tissue vulnerable to further injury.
  • the surfactants themselves can cause irritation or the damaged barrier will permit the passage of other materials that can cause irritation or increase skin sensitivity and allergic reactions (see, e.g., Effendy I, Maibach HI, Contact Dermatitis 1995 Oct; 33(4);217-25; Barany E, Lindberg M, Loden M, Contact Dermatitis 1999 Feb;40(2):98-103).
  • a stable topical formulation comprising a surfactant-free oil-in-water dispersion of a wax or hydrophobic semi- solid that is water resistant and provides aesthetically pleasing tactile properties.
  • the present invention provides a method for preparing a surfactant- free oil-in-water wax dispersion comprising a hydrophobic phase comprising a wax, mixed with an aqueous phase.
  • the hydrophobic phase further comprises one or more hydrophobic components which may include a plasticizing agent, a solvent, and a co-solvent.
  • the hydrophobic phase may further comprise other active agents.
  • the aqueous phase may comprise in addition to water, water compatible additives and or modifiers.
  • the aqueous phase further comprises a dispersion initiator.
  • the method of the invention comprises the steps of first mixing the hydrophobic phase comprising a wax, and optionally other hydrophobic components, and then mixing the hydrophobic phase with the aqueous phase, and subjecting the hydrophobic/aqueous mixture to high pressure, high shear or high pressure/high shear mixing conditions to form a stable oil-in-water wax dispersion.
  • the hydrophobic phase is present in an amount of from 1 to 60 wt% of the total dispersion and preferably from 5 to 40 wt%.
  • the aqueous phase is present in an amount of from 40 to 99 wt% of the total dispersion and preferably from 60 to 95 wt%.
  • the wax is shea butter, cocoa butter, carnula wax, petrolatum, castor wax, chamomile wax, bayberry wax, candelilla wax, carnauba wax, clary wax, beeswax, orange peel wax, Japan wax, mink wax, rice bean wax, oricury wax, palm kernel wax, raspberry leaf wax, rosemary flower wax, sweet violet leaf wax, tuberose flower wax, ylang ylang flower wax, everlasting wax, myrtle leaf wax, spermaceti wax, jojoba wax, jotoba butter waxes, and combinations thereof; ceresine wax, ozokerite, parafin wax and microcrystaline wax; synthetic beeswax, synthetic candelilla wax, synthetic carnauba wax, or synthetic spermaceti; cetyl demithicone, dialkyldimethyl polysiloxane, dimethiconol hydroxystearate, dimethiconol stearate, stearoxyme
  • Additional hydrophobic components are selected from the group consisting of hydrogenated castor oil, hydrogenated cottonseed oil, hydrogenated jojoba oil, hydrogenated palm kernel oil, hydrogenated rapeseed oil and hydrogenated rice bran wax.
  • the dispersion initiator is preferably phospholipid, lecithin, or combinations thereof.
  • the dispersion initiator is present in an amount of from 0.01 to 10.0 wt% of the total dispersion and preferably from 0.1 to 5.0 wt%.
  • the plasticizing agent is preferably cyclomethicone, hydrogenated polyisobutene, polyethylene glycol fluid or butylene glycol.
  • the plasticizing agent is present in an amount of from 0.5 to 30 wt% of the total dispersion and preferably from 1.0 to 20 wt%.
  • the solvent and co-solvent are preferably silicone or silicon derivatives such as cyclomethicone; hydrogenated polyisobutene; polymers of ethylene oxides such as polyethylene glycol; or butylene glycol.
  • the solvent is present in an amount of from 5.0 to 50 wt% of the total dispersion and preferably from 10 to 40 wt%.
  • the co- solvent is present in an amount of from 1.0 to 25 wt% of the total dispersion and preferably from 2 to 20 wt%.
  • the present invention provides an oil in water wax dispersion prepared by the method of the invention.
  • the dispersion comprises a hydrophobic phase comprising a wax, mixed with an aqueous phase.
  • the hydrophobic phase further comprises one or more hydrophobic components which may include a plasticizing agent, a solvent, and a co-solvent.
  • the hydrophobic phase may further comprise other active agents.
  • the aqueous phase may comprise in addition to water, water compatible additives and or modifiers.
  • the aqueous phase further comprises a dispersion initiator.
  • the hydrophobic phase is present in an amount of from 1 to 60 wt% of the total dispersion and preferably from 5 to 40 wt%.
  • the aqueous phase is present in an amount of from 40 to 99 wt% of the total dispersion and preferably from 60 to 95 wt%.
  • the wax is shea butter, cocoa butter, carnula wax, petrolatum, castor wax, chamomile wax, bayberry wax, candelilla wax, carnauba wax, clary wax, beeswax, orange peel wax, Japan wax, mink wax, rice bean wax, oricury wax, palm kernel wax, raspberry leaf wax, rosemary flower wax, sweet violet leaf wax, tuberose flower wax, ylang ylang flower wax, everlasting wax, myrtle leaf wax, spermaceti wax, jojoba wax, jotoba butter waxes, and combinations thereof; ceresine wax, ozokerite, parafin wax and microcrystaline wax; synthetic beeswax, synthetic candelilla wax, synthetic carnauba wax, or synthetic spermaceti; cetyl demithicone, dialkyldimethyl polysiloxane, dimethiconol hydroxystearate, dimethiconol stearate, stearoxyme
  • Additional hydrophobic components are selected from the group consisting of hydrogenated castor oil, hydrogenated cottonseed oil, hydrogenated jojoba oil, hydrogenated palm kernel oil, hydrogenated rapeseed oil and hydrogenated rice bran wax.
  • the dispersion initiator is preferably phospholipid, lecithin, or combinations thereof.
  • the dispersion initiator is present in an amount of from 0.01 to 10.0 wt% of the total dispersion and preferably from 0.1 to 5.0 wt%.
  • the plasticizing agent is preferably cyclomethicone, hydrogenated polyisobutene, polyethylene glycol fluid or butylene glycol.
  • the plasticizing agent is present in an amount of from 0.5 to 30 wt% of the total dispersion and preferably from 1.0 to 20 wt%.
  • the solvent and co-solvent are preferably silicone or silicon derivatives such as cyclomethicone; hydrogenated polyisobutene; polymers of ethylene oxides such as polyethylene glycol; or butylene glycol.
  • the solvent is present in an amount of from 5.0 to 50 wt% of the total dispersion and preferably from 10 to 40 wt%.
  • the co-solvent is present in an amount of from 1.0 to 25 wt% of the total dispersion and preferably from 2 to 20 wt%.
  • the present invention provides a composition comprising a) a dispersion prepared by the method of the invention; and b) a base composition comprising water and a hydrophilic rheological modifying agent.
  • the composition comprises the dispersion of a mixture of a hydrophobic phase comprising a wax and an aqueous phase which has been subjected to high pressure, high shear, or high pressure/high shear conditions until a dispersion is obtained.
  • the dispersion is then mixed with the base composition to form the composition of the invention.
  • the hydrophobic phase of the dispersion further comprises one or more hydrophobic components. Hydrophobic components may include a plasticizing agent, a solvent and a co-solvent.
  • the hydrophobic phase may further comprise other active agents.
  • the aqueous phase of the dispersion may further comprise thickeners, a dispersion initiator and one or more active agents.
  • the dispersion is present in an amount of from about 0.1 to about 80 wt% and preferably from about 0.5 to about 40 wt % of the composition.
  • the base composition is present in an amount of from about 20 to 99 wt% of the composition.
  • the base composition typically comprises from about 0.001 to about 50% and preferably from about 0.01 to about 10%, and more preferably from about 0.1 to about 5% by weight of hydrophilic rheological modifying agents.
  • the base composition typically comprises from about 0.001 to about 99.99%), preferably from about 1 to about 99.99%, and more preferably from about 20 to about 99.99% by weight of water.
  • the composition may further include other surfactant-free oil-in-water dispersions or other additives/ modifiers such as are required for the final product.
  • the composition may be prepared by mixing the dispersion with the aqueous base composition using methods known in the art.
  • Suitable hydrophilic rheological modifying agents for the base composition include hydrophilic gelling agents including carboxyvinyl polymers, acrylic copolymers, polyacrylamides, polysaccharides, natural gums and clays, or phosphorylated starch derivatives.
  • the composition may further comprise other additives such as physiological actives and/or aesthetic modifiers such as fragrance, chelating agents, colorants and antioxidants as required or suitable for the preparation of topical compositions for the treatment of dermal, otic, anal, oral, vaginal, nasal and opthalmic disorders.
  • additives are typically mixed with the dispersion and other ingredients using processes and equipment known in the art.
  • the wax is first heated and melted with the plasticizing agent and one or more solvents and co-solvents, mixed with the aqueous composition comprising a dispersion initiator, and then passed through high pressure and high shear processing to produce an oil in water dispersion of a controlled particle size and uniformity.
  • the resulting high pressure and high shear dispersion compositions can be used for prepare a topical composition by the dispersion with low shear in the surfactant-free base composition.
  • the resulting composition may be in the form of a lotion, cream, paste, serum or spray.
  • the method of the present invention forms a stable surfactant-free dispersion comprising one or more waxes or other hydrophobic semi-solids, optionally plasticizing agents and/or solvents or co-solvents, and an aqueous phase optionally comprising a dispersion inhibitor.
  • the dispersions formed by the method of the invention have particle size in the range of from about 0.1 to 5.0 microns.
  • the dispersions may be used in topical formulations for cosmetic or pharmaceutical applications, in the form of a lotion, cream, paste, serum or spray. These formulations have a more emollient and luxurious feel, and have a reduced irritation potential compared to prior art formulations. Definitions
  • wax unless specified otherwise, means a hydrophobic semi-solid material, as defined herein below.
  • surface-active or “surface-active agent” refers to a substance capable of reducing the surface tension of a liquid in which it is dissolved.
  • a “non-surface active agent” is a substance which does not significantly reduce the surface tension of a liquid in which it is dissolved or dispersed.
  • surfactant refers to a surface-active substance.
  • surfactant-free refers to dispersions or compositions that are produced without the use of surface-active ingredients.
  • the composition preferably comprises less than about 3% by weight and more preferably less than about 1% by weight of emulsifying surfactants, based upon 100% weight of total composition.
  • composition or “oil-in-water dispersion” are used interchangeably herein, and refer to the suspension of an oil (or nonpolar substance) or hydrophobic phase or component in a polar (for example, aqueous) composition.
  • dispenser initiator refers to a material that facilitates the mixing of the hydrophobic and hydrophilic phases, i.e., agents that help to initiate the micellularization process. These agents may be present in an amount of from about 0.01 to about 5.0 wt% of the total dispersion. Suitable agents include phospholipids which have low dissociation constants of about in the range of about of 10" 10 to 10"
  • a composition prepared using a dispersion initiator is considered to be substantially free of emulsifying surfactants.
  • a plasticizing agent renders a material to which it is added softer, more pliable or more malleable. Hydrophobic semi-solids
  • Hydrophobic semi-solids are hydrophobic compounds which produce a solid, semi-solid or paste consistency at 25°C and which melt at a temperature of between about 27°C and 150°C.
  • Hydrophobic semi-solids suitable for the present invention include hydrocarbons, modified hydrocarbons, silicones or hydrocarbon derivatives of silicone.
  • Preferred hydrophobic semi-solids include waxes, cocoa butter and shea butter.
  • Waxes of the present invention are composed of one or more saturated, unsaturated, linear, branded or cyclic hydrocarbon chains.
  • An example of a suitable hydrocarbon compounds are illustrated by the following formula:
  • Eutectic blends of these compounds can also be combined to produce other waxes, greases or other hydrophobic semi-solids.
  • Such blends include, but are not limited to cocoa butter, shea butter, castor wax, chamomile wax, bayberry wax, candelilla wax, carnauba wax, clary wax, beeswax, orange peel wax, Japan wax, mink wax, rice bean wax, oricury wax, palm kernel wax, raspberry leaf wax, rosemary flower wax, sweet violet leaf wax, tuberose flower wax, ylang ylang flower wax, everlasting wax, myrtle leaf wax, spermaceti wax, jojoba wax, joBoba butter waxes.
  • Waxes can be produced by reducing or partially reducing unsaturated fatty acids or esters.
  • waxes include but are not limited to: hydrogenated castor oil, hydrogenated cottonseed oil, hydrogenated jojoba oil, hydrogenated palm kernel oil, hydrogenated rapeseed oil and hydrogenated rice bran wax.
  • waxes are derived from petroleum and include, but are not limited to ceresine wax, ozokerite, paraffin wax and microcrystalline wax.
  • Waxes can be formed naturally such as beeswax or their components can be prepared synthetically such as synthetic beeswax, synthetic candelilla wax, synthetic carnauba wax, or synthetic spermaceti. Waxes can also be derivatized with silicone fractions to modify their properties. Examples include cetyl demithicone, dialkyldimethyl polysiloxane, dimethiconol hydroxystearate, dimethiconol stearate, stearoxymethicone/dimethicone copolymer and stearoxytrimethylsilane.
  • Suitable dispersion initiators include phospholipids and lecithins.
  • Phospholipids which have a critical micelle concentration (cmc) of the order of 10 "10 to 10 "30 M, do not exist as free molecules in water based dispersions, but form very stable lipid bilayers.
  • Surfactants on the other hand, which have a cmc in the range of 0.1 to 30 mM, when dispersed in water merely reduce the surface tension of the water.
  • the high stability of lipids in self-assembled microstrucrures is very important in the formation of surfactant-free emulsions.
  • the dispersion may comprise from 0.01% to 8% by weight (preferably 0.01 to 5% by weight) of one or more non-surfactant phospholipids.
  • exemplary phospholipids include Phospholipon 80, 80H (American
  • the dispersion may also include one or more lecithins, for example Alcolec ® (American Lecithin, Oxford, CT).
  • lecithins for example Alcolec ® (American Lecithin, Oxford, CT).
  • a solvent is defined as a fluid or solid into which one or more waxes or hydrophobic semi-solids are dissolved.
  • a co-solvent is a second solvent added to the original solvent to increase the dissolution of the wax or hydrophobic semi-solid. Amounts and selections of solvent and, if desired co-solvents, appropriate for the dispersions of the invention are readily determined in order to facilitate the dissolution of the wax.
  • the solvents and co- solvents used in the present invention can be, but are not limited to, low polar to non- polar materials.
  • the solvent is a fluid at ambient temperature but can be a solid such as a wax, grease or paste which has been converted to a fluid by heating to a temperature exceeding its melting point before the addition of the solvent.
  • Suitable solvents and co-solvents that may be used in the present invention have the following formula:
  • n is an integer from 6 to greater than 1 million and x is 0 or an even integer no greater than n.
  • These materials may include saturated, unsaturated, branched and cyclic hydrocarbon chains.
  • solvents and co-solvents include mineral oil, petrolatum, polybutylenes and hydrogenated polyisobutene.
  • solvents and co-solvents are the mono, di, tri or poly- branches, -cyclic, -saturated or unsaturated alkyl esters or ethers of di, tri or polyhydroxy compounds such as ethylene glycol, propylene glycol, glycerin, sorbitol or polyol.
  • An example of a preferred material is a propylene glycol monoisostearate.
  • branched, saturated or unsaturated vegetable oils such as soybean oil, babassu oil, castor oil, cottonseed oil, Chinese tallow oil, crambe oil, perilla oil, Danish rapeseed oil, rice bran oil, palm oil, palm kernel oil, olive oil, linseed oil, coconut oil, sunflower oil, safflower oil, peanut oil, and corn oil.
  • Preferred saturated and unsaturated vegetable oils are those having fatty acid components with 6 to 24 carbon atoms.
  • Ri and R are saturated, unsaturated, branched or cyclic alkyl radicals of 2 to 24 carbon atoms and n is an integer from 0 to about 20.
  • Suitable esters include isopropyl palmitate and diisopropyl adipate.
  • Ri is a saturated, unsaturated, branched or cyclic alkyl radical from C 2 to C 24 ;
  • M ⁇ is defined by NR 2 R 3 R 4 R 5j wherein R 2 , R 3 and Rt are hydrogen or a saturated, unsaturated or branched alkyl or hydroxalkyl radical from to C 10 ;
  • R 5 is a saturated, unsaturated, branched or cyclic alkyl or substituted alkyl radical from C to C 4 .
  • An example of the above is lauramine oleate.
  • n is an integer from 0 to about 3.
  • These materials can be either a homogenous polymer or a copolymer of two or more monomers.
  • homogeneous polymers include polyethylene oxide, polypropylene oxide and polybutylene oxide. Typically, the molecular weights of these materials are between 100 and 10,000 daltons.
  • Preferred solvents or co- solvents include PEG-4 and PEG-8 (Dow Chemical). Additionally, these materials can be condensed with a mono or polyhydroxyalkyl alcohol as exemplified by the UCON fluids from the Dow Chemical Company.
  • the solvent and co-solvents are preferably silicone and/or silicone derivatives.
  • the silicone is insoluble in water.
  • Suitable water-insoluble silicone materials include, but are not limited to, cyclomethicone, polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, polysiloxane gums and polyethersiloxane copolymers. Examples of suitable silicone materials are disclosed in U.S. Patent Nos. 4,788,006; 4,341,799; 4,152,416; 3,964,500; 3,208,911; 4,364,837 and 4,465,619, all of which are incorporated herein by reference.
  • Exemplary silicone and silicone derivatives include branched or linear cyclical silicone or silicone derivatives, cyclomethicone, dimethicone polysiloxane, dimethiconol, polysiloxanes, polysiloxane copolymers, polyalkyl aryl silanes, polyaryl siloxanes, and polyalkyl siloxanes.
  • Preferred examples of silicone solvents or co-solvents include: low viscosity dimethicone, phenyl trimethicone (Dow Corning) and silicone fluid DC 345 (Dow Corning).
  • plasticizing agents include cyclomethicone, hydrogenated polyisobutene, polyethylene glycol fluid and butylene glycol.
  • compositions of the invention may comprise preservatives such as Phenonip (NIPA Laboratories, Wilmington, DE); GermazideTM MPB (Collaborative Laboratories, Inc. East Setauket, NY); and polyoxethylene ethers.
  • Base Composition Rheological modifying agents also referred to herein as thickeners, within the scope of the invention include any substance which increases or decreases the viscosity of the wax containing composition.
  • Suitable rheological modifying agents include, but are not limited to, phosphorylated starch derivatives, carbohydrate based rheological modifying agents, polymeric and copolymeric rheological modifying agents, inorganic rheological modifying agents, protein rheological modifying agents, polypeptide rheological modifying agents, and any combination of any of the foregoing.
  • phosphorylated starch derivative includes, but is not limited to, starches containing a phosphate group. Suitable phosphorylated starch derivatives include, but are not limited to, hydroxyalkyl starch phosphates, hydroxyalkyl distarch phosphates, and any combination of any of the foregoing. Non- limiting examples of hydroxyalkyl starch phosphates and hydroxyalkyl distarch phosphates include hydroxyethyl starch phosphate, hydroxypropyl starch phosphate, hydroxypropyl distarch phosphate (including sodium hydroxypropyl starch phosphate), and any combination of any of the foregoing.
  • Non-limiting examples of suitable carbohydrate based rheological modifying agents include algin and derivatives and salts thereof, such as algin, calcium alginate, propylene glycol alginate, and ammonium alginate; carrageenan (Chondrus crispus) and derivatives and salts thereof, such as calcium carrageenan and sodium carrageenan; agar; cellulose and derivatives thereof, such as carboxymethyl hydroxyethylcellulose, cellulose gum, cetyl hydroxyethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, methylcellulose, ethylcellulose, and cellulose gum; chitosan and derivatives and salts thereof, such as hydroxypropyl chitosan, carboxymethyl chitosan, and chitin; gellan gum; guar (Cyanopsis tetragonoloba) and derivatives thereof, such as guar hydroxypropyltrimonium chloride
  • Non-limiting examples of suitable polymeric and copolymeric rheological modifying agents include acrylates, methacrylates, polyethylene and derivatives thereof, and any combination of any of the foregoing.
  • Suitable acrylates and methacrylates include, but are not limited to, carbomer and derivatives and salts thereof, acrylate/Cio-Cso alkyl acrylate crosspolymer, acrylate/ceteth-20 itaconate copolymer, acrylate/ceteth-20 methacrylate copolymers, acrylate/steareth-20 methacrylate copolymers, acrylate/steareth-20 itaconate copolymers, acrylate/steareth-50 acrylate copolymers, acrylate/VA crosspolymers, acrylate/vinyl isodecanoate crosspolymers, acrylic acid/acrylonitrogen copolymers, ammonium acrylate/acrylonitrogen copolymers, glyceryl polymethacrylate, polyacryl
  • Non-limiting examples of suitable inorganic thickening agents include clays and derivatives thereof, silicates, silicas and derivatives thereof, and any combination of any of the foregoing.
  • Suitable clays and derivatives thereof include, but are not limited to, bentonite and derivatives thereof, such as quaternium-18 bentonite; hectorite and derivatives thereof, such as quaternium-18 dectorite; montmorillonite; and any combination of any of the foregoing.
  • Suitable silicates include, but are not limited to, magnesium aluminum silicate, sodium magnesium silicate, lithium magnesium silicate, tromethamine magnesium aluminum silicate, and any combination of any of the foregoing.
  • Suitable silicas and derivatives thereof include, but are not limited to, hydrated silica, hydrophobic silica, and any combination of any of the foregoing.
  • Suitable protein and polypeptide rheological modifying agents include, but are not limited to, proteins and derivatives and salts thereof, polypeptides and derivatives and salts thereof, and any combination of any of the foregoing.
  • Non- limiting examples of protein and polypeptide rheological modifying agents include albumin, gelatin, keratin and derivatives thereof, fish protein and derivatives thereof, milk protein and derivatives thereof, wheat protein and derivatives thereof, soy protein and derivatives thereof, elastin and derivatives thereof, silk protein and derivatives thereof, and any combination of any of the foregoing.
  • Preferred rheological modifying agents include, but are not limited to, carbomer, acrylate/alkyl acrylate crosspolymers, acrylate/vinyl isododecanoate crosspolymer, xantham gum, locust bean gum, guar gum, and any combination of any of the foregoing.
  • a more preferred combination of rheological modifying agents comprises carbomer and an acrylate/alkyl acrylate copolymer, such as an acrylate/ o- C 30 alkyl acrylate crosspolymer.
  • carbomer is a homopolymer of acrylic acid crosslinked with an allyl ether of pentaerythritol, an allyl ether of sucrose, or an allyl ether of propylene.
  • acrylate/alkyl acrylate crosspolymer includes, but is not limited to, copolymers of alkyl acrylates with one or more monomers of acrylic acid, methacrylic acid, or one of their short chain (i.e. C. 1-4 alcohol) esters, wherein the crosslinking agent is, for example, an allyl ether of sucrose or pentaerytritol.
  • the alkyl acrylates are C 10 -C 3 o alkyl acrylates.
  • copolymers include, but are not limited to, those commercially available as CarbopolTM 1342, CarbopolTM 1382, PemulenTM TR-1, and PemulenTM TR-2, from Goodrich Specialty Chemicals of Cleveland, OH.
  • Preferred rheological modifying agents include, but are not limited to hydrophilic gelling agents, such as carboxyvinyl polymers (carbomer), acrylic copolymers (e.g. acrylate/alkyl acrylate copolymers), polyacrylamides, polysaccharides (e.g. hydroxypropylcellulose), natural gums, clays, and any combination of any of the foregoing.
  • the base composition typically comprises from about 0.001 to about
  • the base composition typically comprises from about 0.001 to about 99.99%, preferably from about 1 to about 99.99%), and more preferably from about 20 to about 99.99%) by weight of water.
  • Suitable active agents include, but are not limited to, anti-acne agents, antimicrobial agents, anti-inflammatory agents, analgesics, antierythemal agents, antipruritic agents, antiedemal agents, antipsoriatic agents, antifungal agents, skin protectants, sunscreen agents, vitamins, antioxidants, scavengers, antiirritants, antibacterial agents, antiviral agents, antiaging agents, protoprotection agents, hair growth enhancers, hair growth inhibitors, hair removal agents, antidandruff agents, anti-seborrheic agents, exfoliating agents, wound healing agents, anti-ectoparacitic agents, sebum modulators, immunomodulators, hormones, botanicals, moisturizers, astringents, cleansers, sensates, antibiotics, anesthetics, steroids, tissue healing substances, tissue regenerating substances, amino acids, peptides, minerals, ceramides, biohyaluronic acids, enzymes and any combination of any of the foregoing.
  • Preferred anti-acne agents include, but are not limited to, salicylic acid, retinoic acid, alpha hydroxy acid, benzoyl peroxide, sodium sulfacetamide, clindamycin, and any combination of any of the foregoing.
  • Preferred combinations of anti-acne agents to be incorporated in the composition include salicylic acid, retinoic acid, and hydrocortisone; sodium sulfacetamide and clindamycin; salicylic acid and clindamycin; salicylic acid, alpha hydroxy acid, and tetrahydrozoline.
  • Suitable antimicrobial agents include, but are not limited to, benzalkonium chloride, benzethonium chloride, chlorhexidine gluconate, chloroxylenol, cloflucarban, fluorosalan, hexachlorophene, hexylresorcinol, iodine complex, iodine tincture, para-chloromercuriphenol, phenylmercuric nitrate, thimerosal, vitromersol, zyloxin, triclocarban, triclosan, methyl-benzethonium chloride, nonyl phenoxypoly(ethyleneoxy) ethanol-iodine, para-chloro-meta-xylenol, providone-iodine complex, poloxamer-iodine complex, triclorcarban, undecoylium chloride-iodine complex, and any combination of any of the foregoing.
  • Suitable anti-inflammatory agents include, but are not limited to, alidoxa, allantoin, aloe vera, aluminum acetate, aluminum hydroxide, bismuth subnitrate, boric acid, calamine, casein, cellulose, microporous, cholecatciferol, cocoa butter, cod liver oil, colloidal oatmeal, cysteine hydrochloride, dexpanthenol, dimethicone, glycerin, kaolin, lanolin, live yeast cell derivative, mineral oil, peruvian balsam, petrolatum, protein hydrolysate, racemethionine, shark liver oil, sodium bicarbonate, sulfur, talc, tannic acid, topical starch, vitamin A, vitamin E, white petrolatum, zinc acetate, zinc carbonate, zinc oxide, hydrocortisone, betamethasone, ibuprofen, indomethicin, acetyl salicylic acid, tacrolimus, flucoinolone acet
  • Suitable analgesics include, but are not limited to, diphenhydramine, tripeiennamine, benzocaine, dibucaine, lidocaine, tetracaine, camphor, menthol, phenol, resorcinol, matacresol, juniper tar, methyl salicylate, turpentine oil, capsicum, methyl nicotinate, ⁇ -glucan, and any combination of any of the foregoing.
  • Suitable antierythemal agents include, but are not limited to, tetrahydrozoline and hydrocortisone.
  • Suitable antipruritic agents include, but are not limited to, diphenhydramine, pramoxine, antihistamines, and any combination of any of the foregoing.
  • Suitable antiedemal agents include, but are not limited to, pregnenalone acetate, tannin glycosides, and any combination of any of the foregoing.
  • Suitable antipsoriatic agents include, but are not limited to, caleipotriene, coal tar, anthralin, vitamin A, and any combination of any of the foregoing.
  • Preferred combinations of antipsoriatic agents include, but are not limited to, hydrocortisone, retinoic acid, and alpha hydroxy acid; dovonex, salicylic acid, and a sunscreen agent; indomethacin, salicylic acid, and urea; anthralin and salicylic acid; and anthralin and indomethacin.
  • Other suitable antipsoriatic agents include, but are not limited to, caleipotriene, coal tar, anthralin, vitamin A, and any combination of any of the foregoing.
  • Suitable antifungal agents include, but are not limited to, clioquinol, haloprogin, miconazole nitrate, clotrimazole, metronidazole, tolnaftate, undecylenic acid, iodoquinol, and any combination of any of the foregoing.
  • Suitable skin protectants include, but are not limited to, cocoa butter, dimethicone, petrolatum, white petrolatum, glycerin, polyphosphorylcholine glycol acrylate, shark liver oil, allantoin, and any combination of any of the foregoing.
  • Suitable sunscreen agents include, but are not limited to, ethylhexyl methoxycinnamate, avobenzone, benzophenone-3, octocrylene, titanium dioxide, zinc oxide, and any combination of any of the foregoing.
  • Suitable antioxidants include, but are not limited to, scavengers for lipid free radicals and peroxyl radicals, quenching agents, and any combination of any of the foregoing.
  • Suitable antioxidants include, but are not limited to, tocopherol, BHT, beta-carotene, vitamin A, ascorbic acid, ubiquinol, ferulic acid, azelaic acid, thymol, catechin, sinapic acid, EDTA, lactoferrin, rosmariquinone, hydroxytyrosole, sesamol, 2-thioxanthine, nausin, malvin, carvacone, chalcones, glutathione isopropyl ester, xanthine, melanin, guanisone, lophorphyrins, 8-hydroxyxanthine, 2-thioxanthione, vitamin Bj ⁇ plant alkaloids, catalase, quercetin, tyrosine, SOD, cysteine, methi
  • Suitable vitamins include, but are not limited to, vitamin E, vitamin A palmitate, vitamin D, vitamin F, vitamin Bg, vitamin B3 vitamin Bj2 vitamin C, ascorbyl palmitate, vitamin E acetate, biotin, niacin, DL-panthenol, magnesium ascorbyl phosphate and any combination of any of the foregoing.
  • Suitable amino acids include, but are not limited to, glycine, serine, and any combination of any of the foregoing.
  • the composition preferably includes at least one aesthetic modifying agent.
  • An aesthetic modifying agent is a material that imparts desirable tactile, olfactory, taste or visual properties to the surface to which the composition is applied.
  • the aesthetic modifying agent may be hydrophobic or hydrophilic.
  • the aesthetic modifying agent is preferably hydrophobic and is more preferably an oil, wax, solid or paste. Suitable aesthetic modifying agents include appropriate amounts of those materials suitable for solvents as defined above.
  • Suitable adjuvants which may be incorporated into the base composition include pH adjusters, emollients, conditioning agents, moisturizers, chelating agents, gelling agents, colorants, fragrances, odor masking agents, UV stabilizer, preservatives, and any combination of any of the foregoing.
  • Preferred pH adjusters include aminomethyl propanol, aminomethylpropane diol, triethanolamine, triethylamine, citric acid, sodium hydroxide, acetic acid, potassium hydroxide, lactic acid, and any combination of any of the foregoing.
  • Suitable conditioning agents include cyclomethicone; petrolatum; dimethicone; dimethiconol; silicone, such as cyclopentasiloxane and diisostearoyl trimethylolpropane siloxy silicate; sodium hyaluronate; isopropyl palmitate; soybean oil; linoleic acid; PPG-12/saturated methylene diphenyldiisocyanate copolymer; urea; amodimethicone; trideceth-12; cetrimonium chloride; diphenyl dimethicone; propylene glycol; glycerin; quaternary amines; and any combination of any of the foregoing.
  • the dispersions of the invention are preferably prepared using high pressure high shear processing.
  • High pressure or high shear mixing maybe be performed in equipment which includes homogenizers such as a Microfluidizer, DeBee high pressure homogenizer, a french press and a Gaulin homogenizer or "Rotor Stator” devices such as a Symex mill, a Silverson mill and a Ross mill.
  • the dispersions of the invention may be formed by mixing together the components, including a wax (which is typically the active agent), an apolar solvent (such as silicone), water, PEG and/or butylene glycol, a preservative, and optionally one or more phospholipids or lecithins.
  • a wax which is typically the active agent
  • an apolar solvent such as silicone
  • water PEG and/or butylene glycol
  • a preservative optionally one or more phospholipids or lecithins.
  • the composition is heated (for example, to from about 50°C to from about 80°C) to melt the wax, then mixed with a propeller mixer and/or a homogenizer.
  • the composition is then mixed and subjected to high pressure/high shear processing, to obtain a stable, homogeneous oil-in-water dispersion of the wax.
  • the average pH of the composition is from about 5.0 to 5.5.
  • the composition typically has a specific gravity of from about 0.8 to 1.00.
  • the composition has an initial viscosity of from about 100 cps to greater than 50,000 cps. After 24 hours at 25° C, the viscosity of the composition is about 1,000 cps to greater than 80,000 cps.
  • the wax and the hydrophobic solvent are first heated to the appropriate temperature to melt the wax. The wax and solvent are then added to any further hydrophobic components and the aqueous phase, and mixture subjected to high pressure/high shear processing to obtain a stable, homogeneous oil-in-water dispersion of the wax.
  • the preferred pressure for preparation of this dispersion is between about 11,000 to about 27,000 psi, more preferably 11,000 to about 21,000 psi, most preferably between about 11,000 and 15,000 psi.
  • the dispersion is stable for a commercially relevant period of time, e.g., between about 180 to 720 days when stored at approximate room temperature, in a commercial package.
  • the wax dispersions of the current invention may be used in the preparation of a finalized product for application by the end user.
  • the wax dispersion can be added to a suitable base comprised of water and one or more rheological modifying agents and optionally a dispersion initiator.
  • the composition may be used with surfactants, it is preferred that the composition contains no surface active agents to destabilize the dispersion.
  • the wax dispersion may also be combined with other essentially surfactant-free dispersions comprised of one or more non-polar fluids to modify the textural and/or tactile properties of the finished goods product. Further, the wax dispersion can be combined with a physiologically active material to produce the performance benefit of the final finished goods product.
  • the active ingredients can be either water soluble or not water soluble.
  • Water soluble actives can be added to the water phase of the base while the water insoluble actives are first mixed into a hydrophobic-in-water dispersion then added to the base, the wax dispersions and the aesthetic modifying dispersions.
  • the following examples illustrate various aspects of the present invention. It should be understood that the invention is not limited to the specific examples or the details described therein.
  • compositions 1A-1H were formed by heating the ingredients on a steam bath to approximately 80°C. The ingredients were mixed using a propeller mixer, followed by mixing in a homogenizer, and then subjected to a high pressure/high shear at from 11,000 to 25,000 psi. The components of compositions 1A-1H are shown in Table 1.
  • Compostions 2A-2I were formed by heating on a steam bath to approximately
  • compositions 2A-2I are shown below in Table 2.
  • Cetearyl Alcohol Dispersion was made by first heating a mixture of the ingredients shown in Table 3 in a steam bath to approximately 60°C. The ingredients were maintained at 60°C while being mixed using a propeller mixer, followed by mixing in a homogenizer. Slowly the phospholipid was added, mixed until uniform and then subjected to high pressure/high shear processing at from 11,000 to 25,000 psi.
  • the processed material was transferred to a kettle with a side-swiping capability and mixed. 10% Butylene Glycol was added and the mixing with sideswipe action continued until the product was uniform. The product was then allowed to cool without further agitation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une dispersion cireuse huile dans eau renfermant une ou plusieurs cires ou semi-solides hydrophobes, un initiateur de dispersion, éventuellement un ou plusieurs agents plastifiants ou solvants et/ou co-solvants, et de l'eau. L'invention concerne également un procédé de préparation de ces dispersions cireuses huile dans eau et leur utilisation dans des formulations topiques, orales, anales, ophtalmiques, vaginales, otiques et nasales.
PCT/US2001/021746 2000-07-11 2001-07-11 Procedes a haute pression/cisaillement eleve de preparation de dispersions contenant des cires et autres semi-solides et huiles WO2002004004A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/332,395 US20040018250A1 (en) 2001-07-11 2001-07-11 Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solids and oils
AU2001275888A AU2001275888A1 (en) 2000-07-11 2001-07-11 Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solidds and oils

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21761700P 2000-07-11 2000-07-11
US60/217,617 2000-07-11

Publications (1)

Publication Number Publication Date
WO2002004004A1 true WO2002004004A1 (fr) 2002-01-17

Family

ID=22811801

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021746 WO2002004004A1 (fr) 2000-07-11 2001-07-11 Procedes a haute pression/cisaillement eleve de preparation de dispersions contenant des cires et autres semi-solides et huiles

Country Status (2)

Country Link
AU (1) AU2001275888A1 (fr)
WO (1) WO2002004004A1 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783766B2 (en) 2002-03-06 2004-08-31 Dow Global Technologies Inc. Process for preparing a cosmetic formulation
EP1582200A1 (fr) * 2004-03-31 2005-10-05 Luis Martinez De San Vicente Oliveras Composition cosmétique dépilatoire
FR2881642A1 (fr) * 2005-02-04 2006-08-11 Oreal Composition de revetement des fibres keratiniques comprenant une cire et un alcool gras
EP1700597A1 (fr) * 2005-03-04 2006-09-13 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Composition pharmaceutique comprenant en association ubidecarenone, dexpanthenol et chlorhexidine ou un de ses sels pharmaceutiquement acceptables pour application cutanée
EP1859785A1 (fr) * 2006-05-22 2007-11-28 R.I.C.A S.p.A. Produit dépilatoire à base d'huiles végétales et utilisation d'huiles végétales pour des produits dépilatoires
WO2010149966A1 (fr) * 2009-06-24 2010-12-29 Bell Flavors & Fragrances Duft Und Aroma Gmbh Microparticules et procédé de fabrication de microparticules
WO2012152973A1 (fr) * 2011-05-09 2012-11-15 Cuni Bravo Jorge Composition agglutinante pour peintures
WO2016071804A1 (fr) * 2014-11-04 2016-05-12 45Sec Llc Emulsion pharmaceutique visant a l'equilibre therapeutique des pressions internes de la peau humaine et animale
RU2585373C2 (ru) * 2009-12-08 2016-05-27 Смит & Невью Ортопедикс АГ Ферментная композиция и способ обработки ран
US11850301B2 (en) 2017-05-26 2023-12-26 Church & Dwight Co., Inc. Oral care composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174296A (en) * 1978-12-04 1979-11-13 American Lecithin Company Water soluble lecithin composition
US5723137A (en) * 1993-10-29 1998-03-03 Henkel Kommanditgesellschaft Auf Aktien Process for the production of storage stable wax dispersions
US5833951A (en) * 1994-07-16 1998-11-10 Beiersdorf Ag Emulsifier-free, finely disperse cosmetic or dermatological formulations of the oil-in-water type
US5919398A (en) * 1995-03-31 1999-07-06 Shiseido Co., Ltd. Oil-water mixed composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174296A (en) * 1978-12-04 1979-11-13 American Lecithin Company Water soluble lecithin composition
US5723137A (en) * 1993-10-29 1998-03-03 Henkel Kommanditgesellschaft Auf Aktien Process for the production of storage stable wax dispersions
US5833951A (en) * 1994-07-16 1998-11-10 Beiersdorf Ag Emulsifier-free, finely disperse cosmetic or dermatological formulations of the oil-in-water type
US5919398A (en) * 1995-03-31 1999-07-06 Shiseido Co., Ltd. Oil-water mixed composition

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783766B2 (en) 2002-03-06 2004-08-31 Dow Global Technologies Inc. Process for preparing a cosmetic formulation
US7056496B2 (en) 2002-03-06 2006-06-06 Dow Global Technologies Inc. Sunscreen composition and a process for preparing it
EP1582200A1 (fr) * 2004-03-31 2005-10-05 Luis Martinez De San Vicente Oliveras Composition cosmétique dépilatoire
FR2881642A1 (fr) * 2005-02-04 2006-08-11 Oreal Composition de revetement des fibres keratiniques comprenant une cire et un alcool gras
EP1700597A1 (fr) * 2005-03-04 2006-09-13 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Composition pharmaceutique comprenant en association ubidecarenone, dexpanthenol et chlorhexidine ou un de ses sels pharmaceutiquement acceptables pour application cutanée
EP1859785A1 (fr) * 2006-05-22 2007-11-28 R.I.C.A S.p.A. Produit dépilatoire à base d'huiles végétales et utilisation d'huiles végétales pour des produits dépilatoires
WO2010149966A1 (fr) * 2009-06-24 2010-12-29 Bell Flavors & Fragrances Duft Und Aroma Gmbh Microparticules et procédé de fabrication de microparticules
US9493728B2 (en) 2009-06-24 2016-11-15 Bell Flavors & Fragrances Duft Und Aroma Gmbh Microparticles and method of making microparticles
RU2585373C2 (ru) * 2009-12-08 2016-05-27 Смит & Невью Ортопедикс АГ Ферментная композиция и способ обработки ран
RU2619351C1 (ru) * 2009-12-08 2017-05-15 Смит Энд Невью Ортопедикс Аг Композиция для обработки ран
WO2012152973A1 (fr) * 2011-05-09 2012-11-15 Cuni Bravo Jorge Composition agglutinante pour peintures
US20140121311A1 (en) * 2011-05-09 2014-05-01 Jorge Cuní Bravo Paint Binder Composition
US9062215B2 (en) 2011-05-09 2015-06-23 Jorge CUNÍ BRAVO Paint binder composition
WO2016071804A1 (fr) * 2014-11-04 2016-05-12 45Sec Llc Emulsion pharmaceutique visant a l'equilibre therapeutique des pressions internes de la peau humaine et animale
US11850301B2 (en) 2017-05-26 2023-12-26 Church & Dwight Co., Inc. Oral care composition

Also Published As

Publication number Publication date
AU2001275888A1 (en) 2002-01-21

Similar Documents

Publication Publication Date Title
JP3167645B2 (ja) 中性化された架橋ポリ（２−アクリルアミド−２−メチルプロパンスルホン酸）を含有する界面活性剤を含有しない水中油型エマルションの形態での局所への使用のための組成物
EP1253903B1 (fr) Compositions topiques ne contenant pas de tensioactif et procede de preparation rapide de ces dernieres
US6177071B1 (en) Polar solvent-in-oil emulsions and multiple emulsions
CA2368334C (fr) Compositions cosmetiques aqueuses acides gelifiees comprenant une dispersion moussante biliquide huileuse
US20040018250A1 (en) Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solids and oils
US6387382B1 (en) Water-proof, respirable, skin barrier composition
NZ203953A (en) Skin or hair conditioning compositions
JP2018135359A (ja) 高レベルの水混和性溶媒を含有する、疎水性物質の実質的に界面活性剤を含まないサブミクロン分散液
US6509024B2 (en) Composition in the form of water-in-oil emulsion and its cosmetic uses
JP2001019850A (ja) 水中油型エマルジョンの形態の組成物及びその使用、特に美容のための使用
CA2363125C (fr) Hydratant cosmetique non collant pour peau et cheveux
KR20130109950A (ko) 피부 개선 피부 화장료
WO2007039974A1 (fr) Lotion en émulsion
US20030215470A1 (en) Compositions and methods for preparing dispersions of thickened oils
WO2007024978A2 (fr) Applications de gel silicone reticule dans des produits de soins d'hygiene personnelle
JP2013536299A (ja) サッカリドシロキサンコポリマー乳化剤を含有するエマルション、並びに、これらの調製及び使用方法
WO2001070271A2 (fr) Compositions de base stables utiles pour preparer des compositions topiques sans tensioactifs
WO2002004004A1 (fr) Procedes a haute pression/cisaillement eleve de preparation de dispersions contenant des cires et autres semi-solides et huiles
US20040013698A1 (en) Method for preparing topical preparations containing skin protective agents with enhanced barrier properties
WO2001070270A2 (fr) Compositions de base servant a preparer des compositions topiques exemptes de tensioactif
GB2422605A (en) Ionic thickening agent for compositions
WO2002003925A1 (fr) Procede de preparation de compositions topiques contenant des agents protecteurs de la peau dotes de proprietes barriere ameliorees
KR102557085B1 (ko) 오일 겔화제를 포함하는 수중유형 화장료 조성물 및 이의 제조방법
WO2006075743A1 (fr) Composition pour emulsion de type aqueux
JPH05262618A (ja) 皮膚化粧料

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10332395

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP